14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.470 $0.470 Thursday, 17th Aug 2023 CYAD stock ended at $0.470. During the day the stock fluctuated 0% from a day low at $0.470 to a day high of $0.470.
90 days $0.470 $0.470
52 weeks $0.460 $3.07

Historical Celyad SA prices

Date Open High Low Close Volume
Aug 27, 2019 $12.61 $12.70 $12.27 $12.27 11 083
Aug 26, 2019 $12.42 $12.84 $12.42 $12.84 8 554
Aug 23, 2019 $11.92 $12.66 $11.92 $12.54 7 645
Aug 22, 2019 $12.85 $13.33 $12.52 $12.65 8 054
Aug 21, 2019 $12.75 $13.22 $12.45 $12.98 2 403
Aug 20, 2019 $12.30 $13.13 $12.18 $12.20 16 898
Aug 19, 2019 $12.40 $12.67 $12.30 $12.47 21 749
Aug 16, 2019 $11.57 $12.80 $11.56 $12.26 14 058
Aug 15, 2019 $11.54 $11.91 $11.45 $11.45 7 270
Aug 14, 2019 $11.68 $12.03 $11.42 $11.69 3 940
Aug 13, 2019 $12.21 $12.29 $12.07 $12.29 2 024
Aug 12, 2019 $12.48 $12.54 $12.02 $12.50 5 318
Aug 09, 2019 $12.48 $12.48 $11.95 $11.95 7 148
Aug 08, 2019 $12.54 $13.22 $12.43 $13.22 16 709
Aug 07, 2019 $11.62 $12.29 $11.58 $12.29 7 055
Aug 06, 2019 $11.39 $11.81 $10.34 $10.34 7 634
Aug 05, 2019 $11.57 $11.64 $10.19 $10.75 42 548
Aug 02, 2019 $12.18 $12.26 $11.12 $11.50 46 710
Aug 01, 2019 $12.29 $12.32 $12.01 $12.01 15 451
Jul 31, 2019 $12.32 $12.62 $11.36 $11.36 11 446
Jul 30, 2019 $12.58 $12.69 $12.02 $12.06 16 808
Jul 29, 2019 $13.42 $13.42 $12.89 $13.00 7 651
Jul 26, 2019 $14.02 $14.02 $13.51 $13.61 4 855
Jul 25, 2019 $14.43 $14.43 $13.79 $13.90 2 275
Jul 24, 2019 $14.50 $14.50 $14.13 $14.30 17 045
Click to get the best stock tips daily for free!

About Celyad SA

Celyad SA Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead product candidates include CYAD-101, an allogeneic CAR-T candidate that is in Phase 1b clinical trial for the treatment of metastatic colorectal cancer; CYAD-211, a short hairpin RNA (shRNA)-based allogeneic CAR-T candidate, which is in Phase 1 clinical... CYAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT